Cartesian Therapeutics (RNAC) Current Taxes (2021 - 2022)

Cartesian Therapeutics (RNAC) reported Current Taxes of $320000.0 for Q2 2022, little changed quarter-over-quarter from $320000.0 in Q1 2022.

Cartesian Therapeutics (RNAC) Current Taxes (2021 - 2022) Analysis & Trends

Cartesian Therapeutics (RNAC) has 2 years of Current Taxes data on file, last reported at $320000.0 in Q2 2022.

Current Taxes for Q2 2022 came in at $320000.0, changed N/A year-over-year; the trailing twelve-month figure through Jun 2022 was $320000.0 (changed N/A YoY), and the FY2021 annual result was $601000.0, changed N/A from the prior year.
Current Taxes was little changed at $320000.0 in Q2 2022 per RNAC's latest filing, from $320000.0 in the prior quarter.
Over five years, Current Taxes peaked at $15.8 million in Q3 2021 and troughed at $320000.0 in Q1 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Taxes (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	10,460.56
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	19.20 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	-
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	Cartesian Therapeutics	261.84 Mn	261.84 Mn	-	-

Download Data